PortfoliosLab logoPortfoliosLab logo
RAPT vs. BELFB
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

RAPT vs. BELFB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in RAPT Therapeutics, Inc. (RAPT) and Bel Fuse Inc. (BELFB). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

RAPT vs. BELFB - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
RAPT
RAPT Therapeutics, Inc.
71.30%167.96%-93.64%25.51%-46.09%85.97%-28.47%112.38%
BELFB
Bel Fuse Inc.
16.76%106.32%24.03%104.19%158.73%-12.33%-24.84%39.36%

Fundamentals

Market Cap

RAPT:

$1.56B

BELFB:

$418.73M

EPS

RAPT:

-$3.92

BELFB:

$6.88

PB Ratio

RAPT:

10.29

BELFB:

0.45

Total Revenue (TTM)

RAPT:

$0.00

BELFB:

$675.46M

Gross Profit (TTM)

RAPT:

-$200.00K

BELFB:

$264.42M

EBITDA (TTM)

RAPT:

-$108.01M

BELFB:

$142.97M

Returns By Period

In the year-to-date period, RAPT achieves a 71.30% return, which is significantly higher than BELFB's 16.76% return.


RAPT

1D
0.00%
1M
0.07%
YTD
71.30%
6M
124.97%
1Y
494.47%
3Y*
-38.25%
5Y*
-15.58%
10Y*

BELFB

1D
0.08%
1M
-13.81%
YTD
16.76%
6M
40.51%
1Y
165.14%
3Y*
74.71%
5Y*
59.14%
10Y*
31.01%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RAPT vs. BELFB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RAPT
RAPT Risk / Return Rank: 9898
Overall Rank
RAPT Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
RAPT Sortino Ratio Rank: 9898
Sortino Ratio Rank
RAPT Omega Ratio Rank: 9797
Omega Ratio Rank
RAPT Calmar Ratio Rank: 9999
Calmar Ratio Rank
RAPT Martin Ratio Rank: 9898
Martin Ratio Rank

BELFB
BELFB Risk / Return Rank: 9696
Overall Rank
BELFB Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
BELFB Sortino Ratio Rank: 9494
Sortino Ratio Rank
BELFB Omega Ratio Rank: 9494
Omega Ratio Rank
BELFB Calmar Ratio Rank: 9898
Calmar Ratio Rank
BELFB Martin Ratio Rank: 9898
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RAPT vs. BELFB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for RAPT Therapeutics, Inc. (RAPT) and Bel Fuse Inc. (BELFB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


RAPTBELFBDifference

Sharpe ratio

Return per unit of total volatility

4.73

3.25

+1.47

Sortino ratio

Return per unit of downside risk

4.47

3.36

+1.10

Omega ratio

Gain probability vs. loss probability

1.59

1.46

+0.13

Calmar ratio

Return relative to maximum drawdown

11.35

8.40

+2.95

Martin ratio

Return relative to average drawdown

25.83

24.43

+1.39

RAPT vs. BELFB - Sharpe Ratio Comparison

The current RAPT Sharpe Ratio is 4.73, which is higher than the BELFB Sharpe Ratio of 3.25. The chart below compares the historical Sharpe Ratios of RAPT and BELFB, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


RAPTBELFBDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

4.73

3.25

+1.47

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.13

1.13

-1.26

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.54

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.07

0.23

-0.30

Correlation

The correlation between RAPT and BELFB is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

RAPT vs. BELFB - Dividend Comparison

RAPT has not paid dividends to shareholders, while BELFB's dividend yield for the trailing twelve months is around 0.14%.


TTM20252024202320222021202020192018201720162015
RAPT
RAPT Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
BELFB
Bel Fuse Inc.
0.14%0.17%0.34%0.42%0.85%2.17%1.86%1.37%1.52%1.11%0.91%1.62%

Drawdowns

RAPT vs. BELFB - Drawdown Comparison

The maximum RAPT drawdown since its inception was -98.47%, which is greater than BELFB's maximum drawdown of -81.89%. Use the drawdown chart below to compare losses from any high point for RAPT and BELFB.


Loading graphics...

Drawdown Indicators


RAPTBELFBDifference

Max Drawdown

Largest peak-to-trough decline

-98.47%

-81.89%

-16.58%

Max Drawdown (1Y)

Largest decline over 1 year

-36.08%

-19.94%

-16.14%

Max Drawdown (5Y)

Largest decline over 5 years

-98.14%

-44.50%

-53.64%

Max Drawdown (10Y)

Largest decline over 10 years

-79.79%

Current Drawdown

Current decline from peak

-85.16%

-16.95%

-68.21%

Average Drawdown

Average peak-to-trough decline

-63.85%

-37.08%

-26.77%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.87%

6.86%

+16.01%

Volatility

RAPT vs. BELFB - Volatility Comparison

The current volatility for RAPT Therapeutics, Inc. (RAPT) is 0.51%, while Bel Fuse Inc. (BELFB) has a volatility of 16.73%. This indicates that RAPT experiences smaller price fluctuations and is considered to be less risky than BELFB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


RAPTBELFBDifference

Volatility (1M)

Calculated over the trailing 1-month period

0.51%

16.73%

-16.22%

Volatility (6M)

Calculated over the trailing 6-month period

69.27%

33.33%

+35.94%

Volatility (1Y)

Calculated over the trailing 1-year period

119.45%

51.09%

+68.36%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

123.30%

52.48%

+70.82%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

124.92%

58.11%

+66.81%

Financials

RAPT vs. BELFB - Financials Comparison

This section allows you to compare key financial metrics between RAPT Therapeutics, Inc. and Bel Fuse Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober0
175.94M
(RAPT) Total Revenue
(BELFB) Total Revenue
Values in USD except per share items